Skip to main content

Table 3 Intragroup variation of CD34+/CD144+ according to different parameters.

From: Decreased pre-surgical CD34+/CD144+ cell number in patients undergoing coronary artery bypass grafting compared to coronary artery disease-free valvular patients

  CABG Valvular
Sex Men: 0.2276 ± 0.03
Women: 0.1259 ± 0.05 (P = 0.13)
Men: 0.4189 ± 0.08
Women: 0.5423 ± 0.15 (P = 0.54)
EF (%) < Mean: 0.2492 ± 0.05
> Mean: 0.1722 ± 0.03 (P = 0.21)
< Mean:0.5375 ± 0.11
> Mean: 0.4419 ± 0.12 (P = 0.46)
Tobacco Yes: 0.1583 ± 0.05
No: 0.2300 ± 0.03 (P = 0.35)
Yes: 0.43 ± 0.12
No: 0.4835 ± 0.09 (P = 0.52)
Dyslipidemia Yes: 0.1542 ± 0.03
No: 0.3045 ± 0.05 (P = 0.016)
Yes: 0.3363 ± 0.08
No: 0.5412 ± 0.11 (P = 0.38)
Diabetes Yes: 0.2129 ± 0.05
No: 0.2133 ± 0.04 (P = 0.59)
Yes: 0.4160 ± 0.29
No: 0.4809 ± 0.08 (P = 0.43)
Antiplatelet drugs Yes: 0.2330 ± 0.04
No: 0.1767 ± 0.04 (P = 0.66)
Yes: 0.1925 ± 0.09
No: 0.5293 ± 0.09 (P = 0.0238)
Statins Yes: 0.1947 ± 0.03
No: 0.2500 ± 0.06 (P = 0.42)
Yes: 0.1925 ± 0.09
No: 0.5293 ± 0.09 (P = 0.02)
Nitrates Yes: 0.2856 ± 0.06
No: 0.1800 ± 0.03 (P = 0.21)
Yes: 0.4250 ± 0.20
No: 0.4767 ± 0.08 (P = 0.90)
Oral antidiabetics Yes: 0.1944 ± 0.05
No: 0.2217 ± 0.03 (P = 0.31)
Yes: 0.8950 ± 0.68
No: 0.4564 ± 0.08 (P = 0.28)
Insulin Yes: 0.2954 ± 0.07
No: 0.1850 ± 0.03 (P = 0.19)
Yes: 0.09 ± 0 (n = 1)
No: 0.4823 ± 0.08 (P < 0.0001)§
MI < 30 days Yes: 0.2481 ± 0.06
No: 0.1971 ± 0.03 (P = 0.37)
Yes: 0.4749 ± 0.08
No: 0 ± 0 (P < 0.0001)§
EuroSCORE Yes: 0.1852 ± 0.03
No: 0.2575 ± 0.06 (P = 0.46)
Yes: 0.4489 ± 0.16
No: 0.4890 ± 0.09 (P = 0.55)
Platelets Yes: 0.2403 ± 0.04
No: 0.1710 ± 0.04 (P = 0.27)
Yes: 0.3627 ± 0.07
No: 0.6004 ± 0.15 (P = 0.48)
Monocytes < Mean: 0.2015 ± 0.03
> Mean: 0.2252 ± 0.05 (P = 0.71)
< Mean: 0.4668 ± 0.13
> Mean: 0.4821 ± 0.09 (P = 0.48)
Fibrinogen < Mean: 0.2411 ± 0.05
> Mean: 0.1645 ± 0.05 (P = 0.09)
< Mean: 0.3945 ± 0.08
> Mean: 0.4700 ± 0.11 (P = 0.98)
  1. § = Student's t test, = U Mann-Whiney-Wilcoxon test.